Global Pharma Sustained Release Excipient Market Growth 2022-2028
The global market for Pharma Sustained Release Excipient is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Pharma Sustained Release Excipient market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Pharma Sustained Release Excipient market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Pharma Sustained Release Excipient market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Pharma Sustained Release Excipient market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Pharma Sustained Release Excipient players cover Teva Pharmaceutical Industries, Mylan N.V., Valeant Pharmaceuticals International, Pfizer and Sun Pharmaceutical Industries, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Pharma Sustained Release Excipient market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Pharma Sustained Release Excipient market, with both quantitative and qualitative data, to help readers understand how the Pharma Sustained Release Excipient market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Kiloton.
Market Segmentation:
The study segments the Pharma Sustained Release Excipient market and forecasts the market size by Type (Gelatin, Polymers and Minerals), by Application (Pharmaceutical, Health Care and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Gelatin
Polymers
Minerals
Sugars
Chitosan
Segmentation by application
Pharmaceutical
Health Care
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Teva Pharmaceutical Industries
Mylan N.V.
Valeant Pharmaceuticals International
Pfizer
Sun Pharmaceutical Industries
Novartis AG
AstraZeneca
GlaxoSmithKline
Allergan
Janssen Pharmaceuticals
Mayne Pharma Group
BASF
International Flavors & Fragrances
Ashland Global
Evonik Industries
Croda International
Gattefosse
Merck KGaA
Chapter Introduction
Chapter 1: Scope of Pharma Sustained Release Excipient, Research Methodology, etc.
Chapter 2: Executive Summary, global Pharma Sustained Release Excipient market size (sales and revenue) and CAGR, Pharma Sustained Release Excipient market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Pharma Sustained Release Excipient sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Pharma Sustained Release Excipient sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Pharma Sustained Release Excipient market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Teva Pharmaceutical Industries, Mylan N.V., Valeant Pharmaceuticals International, Pfizer, Sun Pharmaceutical Industries, Novartis AG, AstraZeneca, GlaxoSmithKline and Allergan, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharma Sustained Release Excipient Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pharma Sustained Release Excipient by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pharma Sustained Release Excipient by Country/Region, 2017, 2022 & 2028
2.2 Pharma Sustained Release Excipient Segment by Type
2.2.1 Gelatin
2.2.2 Polymers
2.2.3 Minerals
2.2.4 Sugars
2.2.5 Chitosan
2.3 Pharma Sustained Release Excipient Sales by Type
2.3.1 Global Pharma Sustained Release Excipient Sales Market Share by Type (2017-2022)
2.3.2 Global Pharma Sustained Release Excipient Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pharma Sustained Release Excipient Sale Price by Type (2017-2022)
2.4 Pharma Sustained Release Excipient Segment by Application
2.4.1 Pharmaceutical
2.4.2 Health Care
2.4.3 Others
2.5 Pharma Sustained Release Excipient Sales by Application
2.5.1 Global Pharma Sustained Release Excipient Sale Market Share by Application (2017-2022)
2.5.2 Global Pharma Sustained Release Excipient Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pharma Sustained Release Excipient Sale Price by Application (2017-2022)
3 Global Pharma Sustained Release Excipient by Company
3.1 Global Pharma Sustained Release Excipient Breakdown Data by Company
3.1.1 Global Pharma Sustained Release Excipient Annual Sales by Company (2020-2022)
3.1.2 Global Pharma Sustained Release Excipient Sales Market Share by Company (2020-2022)
3.2 Global Pharma Sustained Release Excipient Annual Revenue by Company (2020-2022)
3.2.1 Global Pharma Sustained Release Excipient Revenue by Company (2020-2022)
3.2.2 Global Pharma Sustained Release Excipient Revenue Market Share by Company (2020-2022)
3.3 Global Pharma Sustained Release Excipient Sale Price by Company
3.4 Key Manufacturers Pharma Sustained Release Excipient Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharma Sustained Release Excipient Product Location Distribution
3.4.2 Players Pharma Sustained Release Excipient Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pharma Sustained Release Excipient by Geographic Region
4.1 World Historic Pharma Sustained Release Excipient Market Size by Geographic Region (2017-2022)
4.1.1 Global Pharma Sustained Release Excipient Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pharma Sustained Release Excipient Annual Revenue by Geographic Region
4.2 World Historic Pharma Sustained Release Excipient Market Size by Country/Region (2017-2022)
4.2.1 Global Pharma Sustained Release Excipient Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pharma Sustained Release Excipient Annual Revenue by Country/Region
4.3 Americas Pharma Sustained Release Excipient Sales Growth
4.4 APAC Pharma Sustained Release Excipient Sales Growth
4.5 Europe Pharma Sustained Release Excipient Sales Growth
4.6 Middle East & Africa Pharma Sustained Release Excipient Sales Growth
5 Americas
5.1 Americas Pharma Sustained Release Excipient Sales by Country
5.1.1 Americas Pharma Sustained Release Excipient Sales by Country (2017-2022)
5.1.2 Americas Pharma Sustained Release Excipient Revenue by Country (2017-2022)
5.2 Americas Pharma Sustained Release Excipient Sales by Type
5.3 Americas Pharma Sustained Release Excipient Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharma Sustained Release Excipient Sales by Region
6.1.1 APAC Pharma Sustained Release Excipient Sales by Region (2017-2022)
6.1.2 APAC Pharma Sustained Release Excipient Revenue by Region (2017-2022)
6.2 APAC Pharma Sustained Release Excipient Sales by Type
6.3 APAC Pharma Sustained Release Excipient Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pharma Sustained Release Excipient by Country
7.1.1 Europe Pharma Sustained Release Excipient Sales by Country (2017-2022)
7.1.2 Europe Pharma Sustained Release Excipient Revenue by Country (2017-2022)
7.2 Europe Pharma Sustained Release Excipient Sales by Type
7.3 Europe Pharma Sustained Release Excipient Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharma Sustained Release Excipient by Country
8.1.1 Middle East & Africa Pharma Sustained Release Excipient Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pharma Sustained Release Excipient Revenue by Country (2017-2022)
8.2 Middle East & Africa Pharma Sustained Release Excipient Sales by Type
8.3 Middle East & Africa Pharma Sustained Release Excipient Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharma Sustained Release Excipient
10.3 Manufacturing Process Analysis of Pharma Sustained Release Excipient
10.4 Industry Chain Structure of Pharma Sustained Release Excipient
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharma Sustained Release Excipient Distributors
11.3 Pharma Sustained Release Excipient Customer
12 World Forecast Review for Pharma Sustained Release Excipient by Geographic Region
12.1 Global Pharma Sustained Release Excipient Market Size Forecast by Region
12.1.1 Global Pharma Sustained Release Excipient Forecast by Region (2023-2028)
12.1.2 Global Pharma Sustained Release Excipient Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pharma Sustained Release Excipient Forecast by Type
12.7 Global Pharma Sustained Release Excipient Forecast by Application
13 Key Players Analysis
13.1 Teva Pharmaceutical Industries
13.1.1 Teva Pharmaceutical Industries Company Information
13.1.2 Teva Pharmaceutical Industries Pharma Sustained Release Excipient Product Offered
13.1.3 Teva Pharmaceutical Industries Pharma Sustained Release Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Teva Pharmaceutical Industries Main Business Overview
13.1.5 Teva Pharmaceutical Industries Latest Developments
13.2 Mylan N.V.
13.2.1 Mylan N.V. Company Information
13.2.2 Mylan N.V. Pharma Sustained Release Excipient Product Offered
13.2.3 Mylan N.V. Pharma Sustained Release Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Mylan N.V. Main Business Overview
13.2.5 Mylan N.V. Latest Developments
13.3 Valeant Pharmaceuticals International
13.3.1 Valeant Pharmaceuticals International Company Information
13.3.2 Valeant Pharmaceuticals International Pharma Sustained Release Excipient Product Offered
13.3.3 Valeant Pharmaceuticals International Pharma Sustained Release Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Valeant Pharmaceuticals International Main Business Overview
13.3.5 Valeant Pharmaceuticals International Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Pharma Sustained Release Excipient Product Offered
13.4.3 Pfizer Pharma Sustained Release Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Sun Pharmaceutical Industries
13.5.1 Sun Pharmaceutical Industries Company Information
13.5.2 Sun Pharmaceutical Industries Pharma Sustained Release Excipient Product Offered
13.5.3 Sun Pharmaceutical Industries Pharma Sustained Release Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Sun Pharmaceutical Industries Main Business Overview
13.5.5 Sun Pharmaceutical Industries Latest Developments
13.6 Novartis AG
13.6.1 Novartis AG Company Information
13.6.2 Novartis AG Pharma Sustained Release Excipient Product Offered
13.6.3 Novartis AG Pharma Sustained Release Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Novartis AG Main Business Overview
13.6.5 Novartis AG Latest Developments
13.7 AstraZeneca
13.7.1 AstraZeneca Company Information
13.7.2 AstraZeneca Pharma Sustained Release Excipient Product Offered
13.7.3 AstraZeneca Pharma Sustained Release Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 AstraZeneca Main Business Overview
13.7.5 AstraZeneca Latest Developments
13.8 GlaxoSmithKline
13.8.1 GlaxoSmithKline Company Information
13.8.2 GlaxoSmithKline Pharma Sustained Release Excipient Product Offered
13.8.3 GlaxoSmithKline Pharma Sustained Release Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 GlaxoSmithKline Main Business Overview
13.8.5 GlaxoSmithKline Latest Developments
13.9 Allergan
13.9.1 Allergan Company Information
13.9.2 Allergan Pharma Sustained Release Excipient Product Offered
13.9.3 Allergan Pharma Sustained Release Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Allergan Main Business Overview
13.9.5 Allergan Latest Developments
13.10 Janssen Pharmaceuticals
13.10.1 Janssen Pharmaceuticals Company Information
13.10.2 Janssen Pharmaceuticals Pharma Sustained Release Excipient Product Offered
13.10.3 Janssen Pharmaceuticals Pharma Sustained Release Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Janssen Pharmaceuticals Main Business Overview
13.10.5 Janssen Pharmaceuticals Latest Developments
13.11 Mayne Pharma Group
13.11.1 Mayne Pharma Group Company Information
13.11.2 Mayne Pharma Group Pharma Sustained Release Excipient Product Offered
13.11.3 Mayne Pharma Group Pharma Sustained Release Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Mayne Pharma Group Main Business Overview
13.11.5 Mayne Pharma Group Latest Developments
13.12 BASF
13.12.1 BASF Company Information
13.12.2 BASF Pharma Sustained Release Excipient Product Offered
13.12.3 BASF Pharma Sustained Release Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 BASF Main Business Overview
13.12.5 BASF Latest Developments
13.13 International Flavors & Fragrances
13.13.1 International Flavors & Fragrances Company Information
13.13.2 International Flavors & Fragrances Pharma Sustained Release Excipient Product Offered
13.13.3 International Flavors & Fragrances Pharma Sustained Release Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 International Flavors & Fragrances Main Business Overview
13.13.5 International Flavors & Fragrances Latest Developments
13.14 Ashland Global
13.14.1 Ashland Global Company Information
13.14.2 Ashland Global Pharma Sustained Release Excipient Product Offered
13.14.3 Ashland Global Pharma Sustained Release Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Ashland Global Main Business Overview
13.14.5 Ashland Global Latest Developments
13.15 Evonik Industries
13.15.1 Evonik Industries Company Information
13.15.2 Evonik Industries Pharma Sustained Release Excipient Product Offered
13.15.3 Evonik Industries Pharma Sustained Release Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Evonik Industries Main Business Overview
13.15.5 Evonik Industries Latest Developments
13.16 Croda International
13.16.1 Croda International Company Information
13.16.2 Croda International Pharma Sustained Release Excipient Product Offered
13.16.3 Croda International Pharma Sustained Release Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Croda International Main Business Overview
13.16.5 Croda International Latest Developments
13.17 Gattefosse
13.17.1 Gattefosse Company Information
13.17.2 Gattefosse Pharma Sustained Release Excipient Product Offered
13.17.3 Gattefosse Pharma Sustained Release Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Gattefosse Main Business Overview
13.17.5 Gattefosse Latest Developments
13.18 Merck KGaA
13.18.1 Merck KGaA Company Information
13.18.2 Merck KGaA Pharma Sustained Release Excipient Product Offered
13.18.3 Merck KGaA Pharma Sustained Release Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Merck KGaA Main Business Overview
13.18.5 Merck KGaA Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Pharma Sustained Release Excipient Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pharma Sustained Release Excipient Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Gelatin
Table 4. Major Players of Polymers
Table 5. Major Players of Minerals
Table 6. Major Players of Sugars
Table 7. Major Players of Chitosan
Table 8. Global Pharma Sustained Release Excipient Sales by Type (2017-2022) & (Kiloton)
Table 9. Global Pharma Sustained Release Excipient Sales Market Share by Type (2017-2022)
Table 10. Global Pharma Sustained Release Excipient Revenue by Type (2017-2022) & ($ million)
Table 11. Global Pharma Sustained Release Excipient Revenue Market Share by Type (2017-2022)
Table 12. Global Pharma Sustained Release Excipient Sale Price by Type (2017-2022) & (US$/Ton)
Table 13. Global Pharma Sustained Release Excipient Sales by Application (2017-2022) & (Kiloton)
Table 14. Global Pharma Sustained Release Excipient Sales Market Share by Application (2017-2022)
Table 15. Global Pharma Sustained Release Excipient Revenue by Application (2017-2022)
Table 16. Global Pharma Sustained Release Excipient Revenue Market Share by Application (2017-2022)
Table 17. Global Pharma Sustained Release Excipient Sale Price by Application (2017-2022) & (US$/Ton)
Table 18. Global Pharma Sustained Release Excipient Sales by Company (2020-2022) & (Kiloton)
Table 19. Global Pharma Sustained Release Excipient Sales Market Share by Company (2020-2022)
Table 20. Global Pharma Sustained Release Excipient Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Pharma Sustained Release Excipient Revenue Market Share by Company (2020-2022)
Table 22. Global Pharma Sustained Release Excipient Sale Price by Company (2020-2022) & (US$/Ton)
Table 23. Key Manufacturers Pharma Sustained Release Excipient Producing Area Distribution and Sales Area
Table 24. Players Pharma Sustained Release Excipient Products Offered
Table 25. Pharma Sustained Release Excipient Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Pharma Sustained Release Excipient Sales by Geographic Region (2017-2022) & (Kiloton)
Table 29. Global Pharma Sustained Release Excipient Sales Market Share Geographic Region (2017-2022)
Table 30. Global Pharma Sustained Release Excipient Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Pharma Sustained Release Excipient Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Pharma Sustained Release Excipient Sales by Country/Region (2017-2022) & (Kiloton)
Table 33. Global Pharma Sustained Release Excipient Sales Market Share by Country/Region (2017-2022)
Table 34. Global Pharma Sustained Release Excipient Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Pharma Sustained Release Excipient Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Pharma Sustained Release Excipient Sales by Country (2017-2022) & (Kiloton)
Table 37. Americas Pharma Sustained Release Excipient Sales Market Share by Country (2017-2022)
Table 38. Americas Pharma Sustained Release Excipient Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Pharma Sustained Release Excipient Revenue Market Share by Country (2017-2022)
Table 40. Americas Pharma Sustained Release Excipient Sales by Type (2017-2022) & (Kiloton)
Table 41. Americas Pharma Sustained Release Excipient Sales Market Share by Type (2017-2022)
Table 42. Americas Pharma Sustained Release Excipient Sales by Application (2017-2022) & (Kiloton)
Table 43. Americas Pharma Sustained Release Excipient Sales Market Share by Application (2017-2022)
Table 44. APAC Pharma Sustained Release Excipient Sales by Region (2017-2022) & (Kiloton)
Table 45. APAC Pharma Sustained Release Excipient Sales Market Share by Region (2017-2022)
Table 46. APAC Pharma Sustained Release Excipient Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Pharma Sustained Release Excipient Revenue Market Share by Region (2017-2022)
Table 48. APAC Pharma Sustained Release Excipient Sales by Type (2017-2022) & (Kiloton)
Table 49. APAC Pharma Sustained Release Excipient Sales Market Share by Type (2017-2022)
Table 50. APAC Pharma Sustained Release Excipient Sales by Application (2017-2022) & (Kiloton)
Table 51. APAC Pharma Sustained Release Excipient Sales Market Share by Application (2017-2022)
Table 52. Europe Pharma Sustained Release Excipient Sales by Country (2017-2022) & (Kiloton)
Table 53. Europe Pharma Sustained Release Excipient Sales Market Share by Country (2017-2022)
Table 54. Europe Pharma Sustained Release Excipient Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Pharma Sustained Release Excipient Revenue Market Share by Country (2017-2022)
Table 56. Europe Pharma Sustained Release Excipient Sales by Type (2017-2022) & (Kiloton)
Table 57. Europe Pharma Sustained Release Excipient Sales Market Share by Type (2017-2022)
Table 58. Europe Pharma Sustained Release Excipient Sales by Application (2017-2022) & (Kiloton)
Table 59. Europe Pharma Sustained Release Excipient Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Pharma Sustained Release Excipient Sales by Country (2017-2022) & (Kiloton)
Table 61. Middle East & Africa Pharma Sustained Release Excipient Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Pharma Sustained Release Excipient Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Pharma Sustained Release Excipient Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Pharma Sustained Release Excipient Sales by Type (2017-2022) & (Kiloton)
Table 65. Middle East & Africa Pharma Sustained Release Excipient Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Pharma Sustained Release Excipient Sales by Application (2017-2022) & (Kiloton)
Table 67. Middle East & Africa Pharma Sustained Release Excipient Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Pharma Sustained Release Excipient
Table 69. Key Market Challenges & Risks of Pharma Sustained Release Excipient
Table 70. Key Industry Trends of Pharma Sustained Release Excipient
Table 71. Pharma Sustained Release Excipient Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Pharma Sustained Release Excipient Distributors List
Table 74. Pharma Sustained Release Excipient Customer List
Table 75. Global Pharma Sustained Release Excipient Sales Forecast by Region (2023-2028) & (Kiloton)
Table 76. Global Pharma Sustained Release Excipient Sales Market Forecast by Region
Table 77. Global Pharma Sustained Release Excipient Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Pharma Sustained Release Excipient Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Pharma Sustained Release Excipient Sales Forecast by Country (2023-2028) & (Kiloton)
Table 80. Americas Pharma Sustained Release Excipient Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Pharma Sustained Release Excipient Sales Forecast by Region (2023-2028) & (Kiloton)
Table 82. APAC Pharma Sustained Release Excipient Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Pharma Sustained Release Excipient Sales Forecast by Country (2023-2028) & (Kiloton)
Table 84. Europe Pharma Sustained Release Excipient Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Pharma Sustained Release Excipient Sales Forecast by Country (2023-2028) & (Kiloton)
Table 86. Middle East & Africa Pharma Sustained Release Excipient Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Pharma Sustained Release Excipient Sales Forecast by Type (2023-2028) & (Kiloton)
Table 88. Global Pharma Sustained Release Excipient Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Pharma Sustained Release Excipient Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Pharma Sustained Release Excipient Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Pharma Sustained Release Excipient Sales Forecast by Application (2023-2028) & (Kiloton)
Table 92. Global Pharma Sustained Release Excipient Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Pharma Sustained Release Excipient Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Pharma Sustained Release Excipient Revenue Market Share Forecast by Application (2023-2028)
Table 95. Teva Pharmaceutical Industries Basic Information, Pharma Sustained Release Excipient Manufacturing Base, Sales Area and Its Competitors
Table 96. Teva Pharmaceutical Industries Pharma Sustained Release Excipient Product Offered
Table 97. Teva Pharmaceutical Industries Pharma Sustained Release Excipient Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 98. Teva Pharmaceutical Industries Main Business
Table 99. Teva Pharmaceutical Industries Latest Developments
Table 100. Mylan N.V. Basic Information, Pharma Sustained Release Excipient Manufacturing Base, Sales Area and Its Competitors
Table 101. Mylan N.V. Pharma Sustained Release Excipient Product Offered
Table 102. Mylan N.V. Pharma Sustained Release Excipient Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 103. Mylan N.V. Main Business
Table 104. Mylan N.V. Latest Developments
Table 105. Valeant Pharmaceuticals International Basic Information, Pharma Sustained Release Excipient Manufacturing Base, Sales Area and Its Competitors
Table 106. Valeant Pharmaceuticals International Pharma Sustained Release Excipient Product Offered
Table 107. Valeant Pharmaceuticals International Pharma Sustained Release Excipient Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 108. Valeant Pharmaceuticals International Main Business
Table 109. Valeant Pharmaceuticals International Latest Developments
Table 110. Pfizer Basic Information, Pharma Sustained Release Excipient Manufacturing Base, Sales Area and Its Competitors
Table 111. Pfizer Pharma Sustained Release Excipient Product Offered
Table 112. Pfizer Pharma Sustained Release Excipient Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 113. Pfizer Main Business
Table 114. Pfizer Latest Developments
Table 115. Sun Pharmaceutical Industries Basic Information, Pharma Sustained Release Excipient Manufacturing Base, Sales Area and Its Competitors
Table 116. Sun Pharmaceutical Industries Pharma Sustained Release Excipient Product Offered
Table 117. Sun Pharmaceutical Industries Pharma Sustained Release Excipient Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 118. Sun Pharmaceutical Industries Main Business
Table 119. Sun Pharmaceutical Industries Latest Developments
Table 120. Novartis AG Basic Information, Pharma Sustained Release Excipient Manufacturing Base, Sales Area and Its Competitors
Table 121. Novartis AG Pharma Sustained Release Excipient Product Offered
Table 122. Novartis AG Pharma Sustained Release Excipient Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 123. Novartis AG Main Business
Table 124. Novartis AG Latest Developments
Table 125. AstraZeneca Basic Information, Pharma Sustained Release Excipient Manufacturing Base, Sales Area and Its Competitors
Table 126. AstraZeneca Pharma Sustained Release Excipient Product Offered
Table 127. AstraZeneca Pharma Sustained Release Excipient Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 128. AstraZeneca Main Business
Table 129. AstraZeneca Latest Developments
Table 130. GlaxoSmithKline Basic Information, Pharma Sustained Release Excipient Manufacturing Base, Sales Area and Its Competitors
Table 131. GlaxoSmithKline Pharma Sustained Release Excipient Product Offered
Table 132. GlaxoSmithKline Pharma Sustained Release Excipient Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 133. GlaxoSmithKline Main Business
Table 134. GlaxoSmithKline Latest Developments
Table 135. Allergan Basic Information, Pharma Sustained Release Excipient Manufacturing Base, Sales Area and Its Competitors
Table 136. Allergan Pharma Sustained Release Excipient Product Offered
Table 137. Allergan Pharma Sustained Release Excipient Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 138. Allergan Main Business
Table 139. Allergan Latest Developments
Table 140. Janssen Pharmaceuticals Basic Information, Pharma Sustained Release Excipient Manufacturing Base, Sales Area and Its Competitors
Table 141. Janssen Pharmaceuticals Pharma Sustained Release Excipient Product Offered
Table 142. Janssen Pharmaceuticals Pharma Sustained Release Excipient Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 143. Janssen Pharmaceuticals Main Business
Table 144. Janssen Pharmaceuticals Latest Developments
Table 145. Mayne Pharma Group Basic Information, Pharma Sustained Release Excipient Manufacturing Base, Sales Area and Its Competitors
Table 146. Mayne Pharma Group Pharma Sustained Release Excipient Product Offered
Table 147. Mayne Pharma Group Pharma Sustained Release Excipient Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 148. Mayne Pharma Group Main Business
Table 149. Mayne Pharma Group Latest Developments
Table 150. BASF Basic Information, Pharma Sustained Release Excipient Manufacturing Base, Sales Area and Its Competitors
Table 151. BASF Pharma Sustained Release Excipient Product Offered
Table 152. BASF Pharma Sustained Release Excipient Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 153. BASF Main Business
Table 154. BASF Latest Developments
Table 155. International Flavors & Fragrances Basic Information, Pharma Sustained Release Excipient Manufacturing Base, Sales Area and Its Competitors
Table 156. International Flavors & Fragrances Pharma Sustained Release Excipient Product Offered
Table 157. International Flavors & Fragrances Pharma Sustained Release Excipient Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 158. International Flavors & Fragrances Main Business
Table 159. International Flavors & Fragrances Latest Developments
Table 160. Ashland Global Basic Information, Pharma Sustained Release Excipient Manufacturing Base, Sales Area and Its Competitors
Table 161. Ashland Global Pharma Sustained Release Excipient Product Offered
Table 162. Ashland Global Pharma Sustained Release Excipient Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 163. Ashland Global Main Business
Table 164. Ashland Global Latest Developments
Table 165. Evonik Industries Basic Information, Pharma Sustained Release Excipient Manufacturing Base, Sales Area and Its Competitors
Table 166. Evonik Industries Pharma Sustained Release Excipient Product Offered
Table 167. Evonik Industries Pharma Sustained Release Excipient Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 168. Evonik Industries Main Business
Table 169. Evonik Industries Latest Developments
Table 170. Croda International Basic Information, Pharma Sustained Release Excipient Manufacturing Base, Sales Area and Its Competitors
Table 171. Croda International Pharma Sustained Release Excipient Product Offered
Table 172. Croda International Pharma Sustained Release Excipient Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 173. Croda International Main Business
Table 174. Croda International Latest Developments
Table 175. Gattefosse Basic Information, Pharma Sustained Release Excipient Manufacturing Base, Sales Area and Its Competitors
Table 176. Gattefosse Pharma Sustained Release Excipient Product Offered
Table 177. Gattefosse Pharma Sustained Release Excipient Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 178. Gattefosse Main Business
Table 179. Gattefosse Latest Developments
Table 180. Merck KGaA Basic Information, Pharma Sustained Release Excipient Manufacturing Base, Sales Area and Its Competitors
Table 181. Merck KGaA Pharma Sustained Release Excipient Product Offered
Table 182. Merck KGaA Pharma Sustained Release Excipient Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 183. Merck KGaA Main Business
Table 184. Merck KGaA Latest Developments
List of Figures
Figure 1. Picture of Pharma Sustained Release Excipient
Figure 2. Pharma Sustained Release Excipient Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pharma Sustained Release Excipient Sales Growth Rate 2017-2028 (Kiloton)
Figure 7. Global Pharma Sustained Release Excipient Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pharma Sustained Release Excipient Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Gelatin
Figure 10. Product Picture of Polymers
Figure 11. Product Picture of Minerals
Figure 12. Product Picture of Sugars
Figure 13. Product Picture of Chitosan
Figure 14. Global Pharma Sustained Release Excipient Sales Market Share by Type in 2021
Figure 15. Global Pharma Sustained Release Excipient Revenue Market Share by Type (2017-2022)
Figure 16. Pharma Sustained Release Excipient Consumed in Pharmaceutical
Figure 17. Global Pharma Sustained Release Excipient Market: Pharmaceutical (2017-2022) & (Kiloton)
Figure 18. Pharma Sustained Release Excipient Consumed in Health Care
Figure 19. Global Pharma Sustained Release Excipient Market: Health Care (2017-2022) & (Kiloton)
Figure 20. Pharma Sustained Release Excipient Consumed in Others
Figure 21. Global Pharma Sustained Release Excipient Market: Others (2017-2022) & (Kiloton)
Figure 22. Global Pharma Sustained Release Excipient Sales Market Share by Application (2017-2022)
Figure 23. Global Pharma Sustained Release Excipient Revenue Market Share by Application in 2021
Figure 24. Pharma Sustained Release Excipient Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Pharma Sustained Release Excipient Revenue Market Share by Company in 2021
Figure 26. Global Pharma Sustained Release Excipient Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Pharma Sustained Release Excipient Revenue Market Share by Geographic Region in 2021
Figure 28. Global Pharma Sustained Release Excipient Sales Market Share by Region (2017-2022)
Figure 29. Global Pharma Sustained Release Excipient Revenue Market Share by Country/Region in 2021
Figure 30. Americas Pharma Sustained Release Excipient Sales 2017-2022 (Kiloton)
Figure 31. Americas Pharma Sustained Release Excipient Revenue 2017-2022 ($ Millions)
Figure 32. APAC Pharma Sustained Release Excipient Sales 2017-2022 (Kiloton)
Figure 33. APAC Pharma Sustained Release Excipient Revenue 2017-2022 ($ Millions)
Figure 34. Europe Pharma Sustained Release Excipient Sales 2017-2022 (Kiloton)
Figure 35. Europe Pharma Sustained Release Excipient Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Pharma Sustained Release Excipient Sales 2017-2022 (Kiloton)
Figure 37. Middle East & Africa Pharma Sustained Release Excipient Revenue 2017-2022 ($ Millions)
Figure 38. Americas Pharma Sustained Release Excipient Sales Market Share by Country in 2021
Figure 39. Americas Pharma Sustained Release Excipient Revenue Market Share by Country in 2021
Figure 40. United States Pharma Sustained Release Excipient Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Pharma Sustained Release Excipient Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Pharma Sustained Release Excipient Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Pharma Sustained Release Excipient Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Pharma Sustained Release Excipient Sales Market Share by Region in 2021
Figure 45. APAC Pharma Sustained Release Excipient Revenue Market Share by Regions in 2021
Figure 46. China Pharma Sustained Release Excipient Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Pharma Sustained Release Excipient Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Pharma Sustained Release Excipient Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Pharma Sustained Release Excipient Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Pharma Sustained Release Excipient Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Pharma Sustained Release Excipient Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Pharma Sustained Release Excipient Sales Market Share by Country in 2021
Figure 53. Europe Pharma Sustained Release Excipient Revenue Market Share by Country in 2021
Figure 54. Germany Pharma Sustained Release Excipient Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Pharma Sustained Release Excipient Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Pharma Sustained Release Excipient Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Pharma Sustained Release Excipient Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Pharma Sustained Release Excipient Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Pharma Sustained Release Excipient Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Pharma Sustained Release Excipient Revenue Market Share by Country in 2021
Figure 61. Egypt Pharma Sustained Release Excipient Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Pharma Sustained Release Excipient Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Pharma Sustained Release Excipient Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Pharma Sustained Release Excipient Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Pharma Sustained Release Excipient Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Pharma Sustained Release Excipient in 2021
Figure 67. Manufacturing Process Analysis of Pharma Sustained Release Excipient
Figure 68. Industry Chain Structure of Pharma Sustained Release Excipient
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets